2.4 Congestive Heart Failure, Cardiac Tamponade & Feline Aortic Thromboembolism

Congestive Heart Failure, Cardiac Tamponade & Feline Aortic Thromboembolism

Core Knowledge: Cardiovascular crises frequently present as acute respiratory distress, sudden collapse, or excruciating ischemic pain. Advanced emergency and critical care veterinary technicians must rapidly differentiate cardiogenic pulmonary edema, life-threatening cardiac tamponade, and feline aortic thromboembolism (FATE) to execute immediate life-saving medical and procedural interventions.

---

1. Congestive Heart Failure (CHF): Pathophysiology & Differentiation

Congestive heart failure develops when cardiac pathology impairs forward stroke volume, leading to neurohormonal activation (RAAS and sympathetic stimulation), pathological sodium/water retention, and elevated diastolic filling pressures that transmit backward into venous capillary beds.

Critical Feline Anatomy Note: In cats, the visceral pleural veins drain into the pulmonary veins (left atrium), while the parietal pleural veins drain into the systemic circulation (right atrium). Consequently, cats with Left-Sided CHF frequently develop pleural effusion in addition to or instead of pulmonary edema, unlike dogs where L-CHF almost exclusively produces pulmonary edema.

---

2. Acute Emergency Stabilization of Cardiogenic Pulmonary Edema

When managing severe cardiogenic dyspnea, strict adherence to the "FONP" Emergency Protocol maximizes survival while minimizing stress-induced decompensation.

[Acute Respiratory Distress / Suspected Cardiogenic Pulmonary Edema]
                               │
        ┌──────────────────────┼──────────────────────┐
        ▼                      ▼                      ▼
   [O - Oxygen]         [Sedation]            [F - Furosemide]
   Oxygen cage (40-50%) Butorphanol           2–4 mg/kg IV/IM
   or High-Flow Nasal   0.1–0.25 mg/kg IV/IM  (Repeat q1-2h or CRI)
        │                      │                      │
        └──────────────────────┼──────────────────────┘
                               │
                     [N & P - Vasodilators]
                     • Nitroglycerin (venodilator)
                     • Pimobendan (0.25–0.3 mg/kg PO/IV inodilator)

The "FONP" Protocol & Emergency Drug Actions

1. F - Furosemide (Loop Diuretic):
   • Dose: 2 to 4 mg/kg IV or IM (repeated every 1–2 hours until resting respiratory rate drops $<40 \text{ bpm}$, or initiated as a CRI at $0.5–1.0 \text{ mg/kg/hr}$).
   • Pharmacodynamics: Inhibits the $Na^+/K^+/2Cl^-$ cotransporter in the thick ascending loop of Henle. Crucially, furosemide stimulates local renal prostaglandin production within 5–15 minutes of IV injection, providing immediate systemic venodilation (reducing left atrial preload) long before urinary diuresis begins.
2. O - Oxygen Therapy: Flow-by, oxygen canopy, or temperature/humidity-controlled oxygen cage with an $FiO_2$ of 40% to 50%. Avoid high-stress interventions (e.g., struggling with tight-fitting face masks).
3. N - Nitroglycerin / Sodium Nitroprusside (Vasodilators):
   • Nitroglycerin 2% Ointment: Applied transdermally ($1/4"$ to $1"$ ribbon to shaved inner pinna; always wear gloves). Promotes venodilation, pooling blood in peripheral capacitance vessels to decrease pulmonary capillary hydrostatic pressure.
   • Sodium Nitroprusside: Potent balanced arterial and venous dilator CRI ($0.5–5 \text{ mcg/kg/min}$) for refractory fulminant pulmonary edema with hypertension.
4. P - Pimobendan (Inodilator):
   • Dose: 0.25 to 0.3 mg/kg PO (or injectable IV where available).
   • Dual Action: Sensitizes cardiac troponin C to intracellular calcium (positive inotropy without increasing myocardial oxygen demand) and inhibits Phosphodiesterase III (PDE-III), causing balanced peripheral arteriovenous vasodilation (afterload and preload reduction).
5. Sedation & Stress Reduction (Butorphanol):
   • Administer Butorphanol (0.1 to 0.25 mg/kg IV or IM). Relieves anxiety, decreases sympathetic drive, and slows rapid, shallow ventilatory effort without depressing myocardial contractility.

---

3. Pericardial Effusion & Cardiac Tamponade

Pericardial effusion occurs when fluid accumulates within the non-compliant fibroelastic pericardial space. When intrapericardial pressure exceeds normal right atrial and ventricular diastolic filling pressures, Cardiac Tamponade ensues, halting venous return and causing acute cardiogenic shock.

Clinical Presentation & Diagnostic Landmarks

• Beck's Triad:
  1. Muffled heart sounds (fluid dampens acoustic transmission)
  2. Distended jugular veins (elevated central venous pressure from impaired right atrial filling)
  3. Hypotension / Weak arterial pulses (profoundly diminished stroke volume)
• Pulsus Paradoxus: An abnormal, exaggerated drop in systolic arterial blood pressure ($>10 \text{ mmHg}$) during spontaneous inspiration, palpated as weaker peripheral pulses during inspiration and stronger pulses during expiration.
• Electrical Alternans: Alternating height/amplitude of QRS complexes on ECG from beat to beat, caused by the physical swinging of the heart within the fluid-distended pericardial sac.

Normal Beat 1         Beat 2 (Swung away)      Beat 3 (Swung back)
     ▲                      ▲                      ▲
    ╱ ╲                     │                     ╱ ╲
   ╱   ╲                    │                    ╱   ╲
  ╱     ╲                  ╱ ╲                  ╱     ╲
 ╱       ╲                ╱   ╲                ╱       ╲
[Tall R Wave]        [Short R Wave]        [Tall R Wave]

Emergency Pericardiocentesis Technique

• Anatomical Site: Right 4th to 6th intercostal space at the costochondral junction (the cardiac notch between right middle and caudal lung lobes minimizes lung laceration risk; right-sided approach avoids the major left coronary arteries).
• Patient Positioning: Sternal or left lateral recumbency; aseptic clip and prep; local lidocaine block from skin to pleura.
• Instrumentation: 14–16 gauge over-the-needle catheter (or fenestrated central catheter) attached to an extension set, 3-way stopcock, and 20–60 mL syringe.
• Continuous ECG Monitoring: Mandatory during needle advancement. If the catheter touches the epicardium, it induces ventricular premature complexes (VPCs), ventricular runs, or significant ST-segment elevation ("current of injury"). The operator must immediately withdraw the catheter slightly.
• Fluid Confirmation: Non-clotting hemorrhagic fluid confirms pericardial origin (defibrinated by cardiac motion). If the fluid rapidly clots in a bowl or tube, the operator has inadvertently punctured a cardiac chamber!

---

4. Feline Aortic Thromboembolism (FATE)

FATE is a catastrophic sequel to feline cardiomyopathy (most commonly Hypertrophic Cardiomyopathy [HCM]). Severe left atrial enlargement and sluggish blood flow trigger Virchow's triad (endothelial injury, stasis, hypercoagulability), forming a thrombus in the left auricle that dislodges and lodges at the aortic trifurcation ("saddle thrombus").

The Classic "5 Ps" of FATE

1. Pain: Excruciating, severe pain due to acute ischemic neuromuscular necrosis; cats vocalize and are in extreme distress.
2. Pulselessness: Absence of femoral arterial pulses in both (or one) hindlimbs.
3. Pallor / Poikilothermia: Cold footpads with pale, cyanotic, or slate-blue nail beds; temperature gradient between front and hind limbs ($>2–3^\circ\text{C}$ difference).
4. Paresis / Paralysis: Symmetrical (or asymmetrical) flaccid lower motor neuron hindlimb paraparesis or complete paralysis.
5. Paresthesia / Puffiness: Loss of deep and superficial pain sensation; firm, swollen, painful "woody" gastrocnemius muscles developing within hours.

Acute Medical Stabilization of FATE

• Immediate Analgesia (1st Priority): Pure $\mu$-opioid receptor agonists must be administered immediately: Methadone (0.2–0.3 mg/kg IV/IM) or Fentanyl CRI (2–5 mcg/kg/hr). Avoid NSAIDs due to severe renal hypoperfusion.
• Antithrombotic & Anticoagulant Therapy:
  • Unfractionated Heparin: Initial bolus $100\text{ U/kg IV}$, then $100–200\text{ U/kg SQ q8h}$ (titrate to aPTT $1.5–2\times$ baseline) or Low Molecular Weight Heparin (Enoxaparin): $1.0–1.5\text{ mg/kg SQ q8–12h}$.
  • Clopidogrel (Plavix): Platelet ADP-receptor antagonist. Administer a loading dose of 75 mg/cat PO, then maintain at 18.75 mg/cat PO q24h (FAT CAT study proved superior event-free survival over aspirin).

The Lethal Threat of Reperfusion Injury

When collateral microcirculation opens or the thrombus undergoes partial lysis, the return of arterial blood washes massive amounts of ischemic metabolites back into the central circulation.

• Severe Hyperkalemia ($K^+ > 7–8 \text{ mEq/L}$): Damaged cell membranes leak intracellular potassium into the venous circulation, triggering life-threatening bradyarrhythmias, widened QRS complexes, loss of P waves, and fatal asystole.
• Severe Metabolic Acidosis: Lactic acid washout causes sudden profound systemic acidemia.
• Monitoring & Treatment: Monitor serum potassium and blood gases every 2 to 4 hours post-stabilization. Manage severe hyperkalemia immediately with Regular Insulin (0.1–0.25 U/kg IV) + 50% Dextrose (1–2 g per unit of insulin), 10% Calcium Gluconate (0.5–1.0 mL/kg slow IV) to stabilize myocardial membranes, and balanced fluid therapy.